Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ÎV2 Env
Keywords: Tat protein; ÎV2 Env protein; HIV/AIDS vaccine; Ab; antibodies; AVIP; AIDS Vaccine Integrated Project; CTL; cytotoxic T lymphocyte; ÎV2 Env; V2-deleted Env; ELISA; enzyme-linked immunosorbent assay; GMP; good manufacturing practice; i.d.; intradermal; I